Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuliang Cao

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Nature Communications|December 8, 2023
Crop rotation and native microbiome inoculation restore soil capacity to suppress a root diseaseYanyan Zhou, Zhen Yang, Jinguang Liu, et al.
Plants (Basel, Switzerland)|June 12, 2026
Establishment of a Genetic Transformation System for <i>Hippophae gyantsensis</i> and the Regulatory Role of <i>Hgfw2.2</i> and <i>Hgfw3.2</i> in Fruit SizeYaqing Zhang, Yumeng Gao, Chunxia Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2024
Deforestation impacts soil biodiversity and ecosystem services worldwideXinjing Qu, Xiaogang Li, Richard D Bardgett, et al.
BMC Cancer|July 20, 2023
Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinomaQingwu Du, Xiaoyue Wu, Kunning Zhang, et al.
Frontiers in Immunology|January 20, 2022
Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 BlockadeXiaoxue Ma, Zhoubo Guo, Xiaoying Wei, et al.
Cancer Letters|August 14, 2024
Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapiesHui Huang, Gang Zhao, Tierun Wang, et al.
Oncoimmunology|January 17, 2022
Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockadeCihui Yan, Xiaoxue Ma, Zhoubo Guo, et al.
Eclinicalmedicine|February 2, 2026
Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trialWencheng Zhang, Tian Zhang, Xi Chen, et al.
Cancer Medicine|February 13, 2025
Multi-Institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell CarcinomaFangdong Zhao, Qifeng Wang, Weiming Han, et al.
Frontiers in Immunology|June 5, 2023
Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancerCihui Yan, Hui Huang, Zhunhao Zheng, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Nature Communications|December 8, 2023
Crop rotation and native microbiome inoculation restore soil capacity to suppress a root diseaseYanyan Zhou, Zhen Yang, Jinguang Liu, et al.
Plants (Basel, Switzerland)|June 12, 2026
Establishment of a Genetic Transformation System for <i>Hippophae gyantsensis</i> and the Regulatory Role of <i>Hgfw2.2</i> and <i>Hgfw3.2</i> in Fruit SizeYaqing Zhang, Yumeng Gao, Chunxia Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2024
Deforestation impacts soil biodiversity and ecosystem services worldwideXinjing Qu, Xiaogang Li, Richard D Bardgett, et al.
BMC Cancer|July 20, 2023
Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinomaQingwu Du, Xiaoyue Wu, Kunning Zhang, et al.
Frontiers in Immunology|January 20, 2022
Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 BlockadeXiaoxue Ma, Zhoubo Guo, Xiaoying Wei, et al.
Cancer Letters|August 14, 2024
Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapiesHui Huang, Gang Zhao, Tierun Wang, et al.
Oncoimmunology|January 17, 2022
Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockadeCihui Yan, Xiaoxue Ma, Zhoubo Guo, et al.
Eclinicalmedicine|February 2, 2026
Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trialWencheng Zhang, Tian Zhang, Xi Chen, et al.
Cancer Medicine|February 13, 2025
Multi-Institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell CarcinomaFangdong Zhao, Qifeng Wang, Weiming Han, et al.
Frontiers in Immunology|June 5, 2023
Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancerCihui Yan, Hui Huang, Zhunhao Zheng, et al.
Pageof 16